Think Research Corporation Announces December 31, 2020 Fourth Quarter Financial Results and Full Year Financial Results

  • For the Three months ended December 31, 2020 the Company generated revenue of $3.6 million.
  • Pro-forma Revenue1 for the Twelve months ended December 31, 2020 was $35.8 million.
  • On December 23, 2020, the Company closed its reverse takeover transaction and the acquisition of HealthCarePlus network of clinics.
  • On December 30, 2020, the Company began trading on the TSX.V, raising aggregate gross proceeds of $33 million.                                     

TORONTO, ON – April 28, 2021 – Think Research (TSX.V:THNK) (“THINK” or the “Company”), a leading healthcare technology company focused on transforming healthcare through integrated digital health software solutions, today reported audited financial results for the three months ended December 31, 2020. 

Additional information concerning the company, including its audited financial statements and the Management Discussion and Analysis, can be found under the Company’s profile on SEDAR and on the company’s website.

To align the Company’s fiscal year end to a calendar year end as a public company, THINK changed its financial year end date to December 31. Pro forma revenues for the twelve months ended December 31, 2020 adjust for the impact of revenue earned by companies acquired by THINK on December 23, 2020 and January 29, 2021 as if the Company had made such acquisitions on January 1, 2020.

THINK’s CEO, Sachin Aggarwal said, “By going public and completing recent highly strategic acquisitions, we have laid a strong foundation to accelerate growth in 2021 and beyond. We expect to continue building out high quality, recurring software revenues from top-tier health system clients, while continuing to acquire and integrate additional companies aligned with our mission to ensure everyone gets the best possible care.”

Financial Highlights – Three months ended December 31, 2020

  • The Company achieved Revenue of $3.6 million 
  • Net loss of $13.1 million which included $7.2 million of other expenses primarily related to the Reverse takeover transaction and acquisitions, compared to a net loss of $10.0 million for the year ended September 30, 2020 
  • Adjusted EBITDA1 of $(2.8) million compared to $(2.3) million for the year ended September 30, 2020

Financial Highlights – Pro Forma December 31, 2020 

  • The Company had Pro-Forma Revenue of $35.8 million for the twelve months ended December 31, 2020

Subsequent Events

  • On January 29, 2021, the Company closed the acquisition of MDBriefCase Group Inc., a leading provider of online continuing medical education and professional development solutions for clinicians.                               
  • On January 29, 2021, the Company closed the acquisition of Clinic 360, a Toronto surgical clinic specializing in elective surgeries.
  • On February 19, 2021, the Company announced demand for VirtualCare telemedicine platform increased more than 600 per cent since the beginning of the COVID-19 global pandemic.
  • On March 2, 2021, the Company announced Canada-wide partnership with CareRX to deliver virtual healthcare to seniors.
  • On March 30, 2021, the Company announced multi-year partnership with Iceland’s exclusive hospital record system, Origo, to deploy THINK’s clinical content software.

First Quarter Fiscal 2021 Update

In light of the continued momentum across its product lines, and the strong performance of its recent acquisitions, the Company is providing the following financial guidance for Q1 2021:

  • Forecasted Revenue for the three months ended March 31, 2021 of between $8.0 million to $8.3 million respectively.
  • As a result of the acquisitions that closed on January 29, 2021, only two months of actual results are included in the revenue figure presented above, as opposed to a full three months of revenue.  
  • Integrations from recent acquisitions are ahead of plan, resulting in the realization of certain synergies in the current quarter. 

This guidance is provided to enhance visibility into the Company’s expectations for financial targets for the first quarter. Please refer to the section regarding forward-looking statements which forms an integral part of this press release.  

Conference Call Notification 

The Company will not be holding a conference call for the Q4 2020 financial results. There will be a conference call for the Q1 2021 results which has not yet been announced. 

About Think Research Corporation

Think Research is an industry leader in delivering knowledge-based digital healthcare software solutions. The Company’s focused mission is to organize the world’s health knowledge so everyone gets the best care. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes. For over a decade, Think Research’s cloud-based, EMR-agnostic digital tools have empowered clinicians around the world and positively impacted millions of patients across the continuum of care – including primary physician care, acute care hospitals and surgical suites as well as community and seniors care. Think Research is proud to serve as a trusted health system partner to a rapidly growing, global client base that spans five continents and more than 2,800 healthcare facilities.

Caution Regarding Forward Looking Information 

Certain statements in this news release, other than statements of historical fact, contain “forward-looking information” within the meaning of Canadian securities laws and are based on certain assumptions and reflect the Company’s current expectations with respect to such matters. Forward-looking statements are provided for the purposes of assisting the reader in understanding the Company and its business, operations, prospects and risks at a point in time in the context of historical and possible future developments and the reader is cautioned that such statements may not be appropriate for other purposes. Statements containing forward-looking information are not historical facts, but instead represent management expectations, estimates and projections regarding future events or circumstances. Such forward-looking information is necessarily based on a number of opinions, estimates and assumptions, including but not limited to those assumptions described under the heading “Caution Regarding Forward Looking Information” in the Company’s Management’s Discussion & Analysis for the Three months ended December 31, 2020 (the “MD&A”). These statements may include, without limitation, statements regarding the operations, business, financial condition, expected financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, strategies, competitive strengths and outlook of the Company, and include statements concerning accelerating growth in 2021 and beyond, expectations for continuing to build out high quality, recurring software revenues from top-tier health system clients and continuing to acquire and integrate additional companies, and the statements made under “First Quarter Fiscal 2021 Update”. Forward-looking statements include statements that are predictive in nature, depend upon or refer to future events or conditions, or include words such as “expects”, “anticipates”, “plans”, “believes”, “estimates”, “seeks”, “intends”, “targets”, “projects”, “forecasts”, “committed” or negative versions thereof and other similar expressions, or future or conditional verbs such as “may”, “will”, “should”, “would” and “could”. 

By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, many of which are beyond the Company’s control, affect the operations, performance and results of the Company, and could cause actual results to differ materially from current expectations of estimated or anticipated events or results. These factors include, but are not limited to: the impact or unanticipated impact of general economic, political and market factors in North America and internationally, fluctuations in interest rates, inflation and foreign exchange rates, monetary policies, business investment and the health of local and global equity and capital markets, changes in technology, management of market liquidity and funding risks, risks associated with financial instruments, changes in accounting policies and methods used to report financial condition (including uncertainties associated with significant judgments, estimates and assumptions), reliance on third party services, the effect of applying future accounting changes, privacy and confidentiality risks, product and service defects, medical liability claims, business competition, operational and reputational risks, technological changes, cybersecurity risks, changes in government regulation and legislation, changes in tax laws, unexpected judicial or regulatory proceedings, catastrophic events, man-made disasters, terrorist attacks, wars and other conflicts, or an outbreak of a public health pandemic or other public health crises (such as COVID-19), the Company’s ability to complete strategic transactions, integrate acquisitions and implement other growth strategies, and the Company’s success in anticipating and managing the foregoing factors.  

The reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including management’s perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances and that the list of factors in the previous paragraph, collectively, are not expected to have a material impact on the Company. While the Company considers these assumptions to be reasonable based on information currently available to management, they may prove to be incorrect.

Other than as specifically required by applicable Canadian law, the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made, or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Additional information about the risks and uncertainties of the Company’s business and material factors or assumptions on which information contained in forwardlooking statements is based is provided in its disclosure materials, including the Company’s most recently filed annual information form and any subsequently-filed interim MD&A, which are available under our profile on SEDAR at

Cautionary Note Regarding Non-IFRS Measures 

This press release makes reference to certain non-IFRS measures. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company’s results of operations from management’s perspective. The Company’s definitions of non-IFRS measures used in this MD&A may not be the same as the definitions for such measures used by other companies in their reporting. Non-IFRS measures have limitations as analytical tools and should not be considered in isolation nor as a substitute for analysis of the Company’s financial information reported under IFRS. The Company uses non-IFRS financial measures, including “EBITDA”, “Adjusted EBITDA”, and “Pro-forma Revenue” to provide investors with supplemental measures of its operating performance and to eliminate items that have less bearing on operating performance or operating conditions and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. Specifically, the Company believes that Adjusted EBITDA, when viewed with the Company’s results under IFRS and the accompanying reconciliations, provides useful information about the Company’s business without regard to potential distortions. By eliminating potential differences in results of operations between periods caused by factors such as restructuring, impairment and other charges, the Company believes that Adjusted EBITDA can provide a useful additional basis for comparing the current performance of the underlying operations being evaluated. The Company believes that securities analysts, investors and other interested parties frequently use non-IFRS financial measures in the evaluation of issuers. The Company’s management also uses non-IFRS financial measures in order to facilitate operating performance comparisons from period to period.

EBITDA” means net income (loss) before amortization and depreciation expenses, finance and interest costs, and provision for income taxes.

Adjusted EBITDA” adjusts EBITDA for non-cash stock-based compensation expense, gains or losses arising from redemption of securities issued by the Company, asset impairment charges, gains or losses from disposals of property and equipment, impairment charges on property and equipment, business acquisition costs, and restructuring charges. 

Pro-forma Revenue” means revenue for the twelve months ended December 31, 2020 adjusted for the impact of revenue earned by companies acquired by the Company on December 23, 2020 and January 29, 2021 as if the Company had acquired such companies on January 1, 2020. 

See “Select Information and Reconciliation of Non-IFRS Measures” for a reconciliation of each non-IFRS measure to its most directly comparable IFRS measure in the December 31, 2020 MD&A.

Pro-Forma Financial Information 

Pro Forma Financial Information may not be indicative of THINK’s financial condition  or  results. The pro forma financial information contained in THINK’s  public  disclosure  record  is  presented  for  illustrative purposes  only  as of  its  respective  dates  and may  not   be indicative  of  the current  financial  condition  or results of operations  of  THINK.  

The unaudited pro-forma financial information was derived  from  the  respective  historical financial statements of THINK and its acquisitions that closed on December 23, 2020, and January 29, 2021; certain adjustments and assumptions were made as of such dates for the purposes of the pro-forma financial information. The information upon which these adjustments and assumptions were made was preliminary and these kinds of adjustments and assumptions are difficult to make with complete accuracy. 

Accordingly, the combined business, assets, results of operations and financial condition may differ significantly from those indicated in the unaudited pro-forma financial information, and such variations may negatively impact our financial condition, results of operations and share price.

For Further Information:

Genevieve Tomney
VP, Communications & Investor Relations
Think Research 
Direct: 416-460-5784


  1. Represents a non-IFRS measure. For the relevant definitions see “Cautionary note regarding Non-IFRS Measures” section of this press release. Management believes non-IFRS measures, including EBITDA, Adjusted EBITDA, and Pro-forma Revenue provide supplementary information to IFRS measures used in assessing the performance of the business.